Log in to save to my catalogue

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-L...

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-L...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608411

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population

About this item

Full title

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Biologics, 2021-01, Vol.15, p.463-470

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

To assess the clinical response to ixekizumab following secukinumab failure in patients with psoriatic arthritis.
A retrospective multi-center observational study included psoriatic arthritis (PsA) patients with a history of treatment with secukinumab, further treated with ixekizumab. Primary endpoint was primary response to treatment (drug surv...

Alternative Titles

Full title

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608411

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608411

Other Identifiers

ISSN

1177-5491,1177-5475

E-ISSN

1177-5491

DOI

10.2147/BTT.S326792

How to access this item